Загрузка...
Biomarkers and surrogate endpoints in kidney disease
Kidney disease and its related comorbidities impose a large public health burden. Despite this, the number of clinical trials in nephrology lags behind many other fields. An important factor contributing to the relatively slow pace of nephrology trials is that existing clinical endpoints have signif...
Сохранить в:
| Опубликовано в: : | Pediatr Nephrol |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4646734/ https://ncbi.nlm.nih.gov/pubmed/25980469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-015-3104-8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|